Get all your news in one place.
100's of premium titles.
One app.
Start reading
Latin Times
Latin Times
Lifestyle
Mateo Moreno

GLP-1 Drugs and Anorexia: How Telehealth Loopholes Are Endangering the Most Vulnerable Patients

A medicine distributor displays Mounjaro (tirzepatide) self-injecting GLP-1 prefilled pens at his office in Thane on March 20, 2026. A deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost generic versions of injections like Ozempic after a key patent expired on March 20, 2026. (Credit: Photo by Indranil MUKHERJEE / AFP via Getty Images)

The Briefing:

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.